Inathibitisha ...
Imetafsiriwa kiotomatiki. Dozi na tahadhari: angalia toleo asili la Kiingereza. Soma kwa Kiingereza
Nyumbani / Registered in Nigeria / Pflpisces Panty Liner

Pflpisces Panty Liner

NAFDAC Reg. No. A3-100528 · Drug

Registered with NAFDAC. Registration activeAs of 20 November 2026 · synced automatically from official sources.
Product
Pflpisces Panty Liner
NAFDAC number
A3-100528
Active ingredient
Pantyliners
Strength
NA
Form
NA
Pack size
30 pieces per pack (10 packs per roll)
Manufacturer
Not listed
Applicant (holder)
Pisces Industries Nig Ltd
Approved
10 Dec 2021
Status
Active View on NAFDAC ↗
Registration valid to
1 Dec 2026
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Pantyliners: uses, dosage and brands worldwide

What we found

  • Pflpisces Panty Liner is on the NAFDAC register with an active registration (A3-100528). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Pflpisces Panty Liner

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

LYNAVOY is indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or active hepatic decompensation events (e.g. variceal hemorrhage, ascites, hepatic encephalopathy) [see Use in Specific Populations (8.7) , Clinical Pharmacology (12.3) ] . LYNAVOY is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. …

How to take it and how often
  • The recommended dosage of LYNAVOY is 40 mg taken orally twice daily
  • Swallow tablets whole at least 30 minutes before any food or beverage (other than water)
  • Recommended Dosage The recommended dosage of LYNAVOY is 40 mg orally twice daily
  • Swallow tablets whole at least 30 minutes before any food or beverage (other than water) [see Clinical Pharmacology ]
  • If a dose is missed, take the missed dose as soon as possible and at least 30 minutes before your next meal, then resume the original dosing schedule
  • If a dose is missed by more than 6 hours, skip the dose and resume the original dosing schedule
  • Do not take a double dose to make up for a missed dose
  • Administration Modification for Concomitant Use with Bile Acid Binding Resins Administer LYNAVOY at least 4 hours before or 4 hours after taking a bile acid binding resin [see Drug Interactions , Clinical Pharmacology ]
Strengths it comes in

Tablets: 40 mg of linerixibat, purple, biconvex, round, film-coated tablets debossed with "GS 3JG" on one side. Tablets: 40 mg ( 3 )

Children
  • The safety and efficacy of LYNAVOY have not been established
  • In pediatric patients
Older adults

Of the 119 patients that received LYNAVOY in Study 1, 25 (21%) were aged 65 years and older and 3 (3%) were aged 75 years and older [see Clinical Studies (14) ] . No overall differences in safety or effectiveness were observed between patients 65 to less than 75 years of age and younger adult patients, but greater sensitivity of some older individuals cannot be ruled out [see Clinical Pharmacology (12.3) ] . …

While you are taking it
  • Advise the patient to read the FDA-approved patient labeling (Patient Information)
  • Administration Instructions Instruct patients to take LYNAVOY at least 30 minutes before any food or beverage (other than water) [see Dosage and Administration ]
  • Instruct patients that if they miss a dose of LYNAVOY to take it as soon as possible and at least 30 minutes before their next meal, then resume the original dosing schedule
  • If a dose is missed by more than 6 hours, skip the dose and resume the original dosing schedule
  • Advise patients to not take a double dose to make up for a missed dose [see Dosage and Administration ]. …
Talk to a doctor first if
  • None
  • None
Medicines it may not mix with

Bile Acid Binding Resins : Administer at least 4 hours before or 4 hours after administration of LYNAVOY. ( 7.1 ) 7.1 Effects of Bile Acid Binding Resins on LYNAVOY Instruct patients to take LYNAVOY at least 4 hours before or 4 hours after taking a bile acid binding resin [see Dosage and Administration (2.2) ] . Based on in vitro data, bile acid resins may bind linerixibat in the gut [see Clinical Pharmacology (12.3) ]. Concomitant use of bile acid binding resins with LYNAVOY can potentially inhibit the effects of LYNAVOY on the ileal bile acid transporter (IBAT).

Warnings

Liver Test Elevations: Obtain baseline liver tests (alanine aminotransferase [ALT], aspartate aminotransferase [AST], total bilirubin [TB], direct bilirubin [DB], alkaline phosphatase [ALP]) and monitor the levels per standard clinical practice during treatment. If new liver test elevations occur, monitor ALT, AST, TB, DB, and ALP more frequently. For persistent liver test elevations, discontinue LYNAVOY. ( 5.1 ) Diarrhea: Diarrhea may occur. Advise patient to monitor for dehydration. Treatment interruption or discontinuation may be required if diarrhea persists. ( 5.2 ) Fat-Soluble Vitamin (FSV) Deficiency: Obtain baseline levels and monitor during treatment. …

Possible side effects

The following clinically significant adverse reactions are described elsewhere in labeling: Liver Test Elevations [see Warnings and Precautions (5.1) ] Diarrhea [see Warnings and Precautions (5.2) ] Fat-Soluble Vitamin Deficiency [see Warnings and Precautions (5.3) ] The most common adverse reactions (≥5%) are: diarrhea, abdominal pain, nausea, increased ALT, hemorrhage, increased AST, headache, dyspepsia, gastroesophageal reflux disease, abdominal distension, dizziness, and arthralgia. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Intercept Pharmaceuticals 1-844-782-4278 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary There are no data on the use of LYNAVOY in pregnant women to inform a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Use of LYNAVOY during pregnancy is expected to result in minimal fetal exposure because systemic absorption following oral administration is low [see Clinical Pharmacology (12.3) ] . …

If you take too much

Dose-dependent increases in the incidence of gastrointestinal adverse reactions have been observed with LYNAVOY dosages 4.5-fold higher than the recommended dosage. There is no specific antidote for LYNAVOY. If an overdose occurs, discontinue LYNAVOY, monitor the patient for any signs and symptoms and institute general supportive measures as needed. Consider contacting the Poison Help line (1-800-222-1222) or a medical toxicologist for additional overdose management recommendations.

How to store it

Store at 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in the original package to protect from moisture. Keep the bottle tightly closed.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-07-29.

Label for Pflpisces Panty Liner, the active ingredient registered with NAFDAC.

Check your pack of Pflpisces Panty Liner

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Pflpisces Panty Liner

What is in Pflpisces Panty Liner?

Pflpisces Panty Liner contains Pantyliners (NA), as na, according to its NAFDAC registration record.

Is Pflpisces Panty Liner registered with NAFDAC?

Yes. Pflpisces Panty Liner is listed on the NAFDAC register under registration number A3-100528, and its registration is active as of 20 November 2026.

Has Pflpisces Panty Liner been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Pflpisces Panty Liner in our automatically synced alert list.

How can I check that my pack of Pflpisces Panty Liner is genuine?

Run a free authenticity scan with the NAFDAC number A3-100528, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Pflpisces Panty Liner?

Follow your prescription or the leaflet in your pack. The official label says: The recommended dosage of LYNAVOY is 40 mg taken orally twice daily. Swallow tablets whole at least 30 minutes before any food or beverage (other than water). ( 2.1 ) 2.1 Recommended Dosage The recommended dosage of LYNAVOY is 40 mg orally twice daily. Swallow tablets whole at least 30 minutes before any food or beverage (other than water) [see Clinical Pharmacology (12.3) ] . …

What is Pflpisces Panty Liner used for?

LYNAVOY is indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or active hepatic decompensation events (e.g. variceal hemorrhage, ascites, hepatic encephalopathy) [see Use in Specific Populations (8.7) , Clinical Pharmacology (12. (Summarised from the official U.S. FDA label for Pflpisces Panty Liner. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Pflpisces Panty Liner? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.